Finance

Lists
Why is 532637 down 2,37%?
Dive Deeper
532637:BOM
Mangalam Drugs and Organics Ltd
30,88 INR
-2,37%
(-0,75) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532637...
Open
31,63 INR
High
31,99 INR
Low
30,62 INR
Mkt. cap
490,68 მლნ.
Avg. vol.
10,06 ათ.
Volume
4,23 ათ.
52-wk high
72,95 INR
52-wk low
22,70 INR
EPS
-24,16 INR
Shares outstanding
15,83 მლნ.
No. of employees
319
Open
31,63 INR
High
31,99 INR
Low
30,62 INR
Mkt. cap
490,68 მლნ.
Avg. vol.
10,06 ათ.
Volume
4,23 ათ.
52-wk high
72,95 INR
52-wk low
22,70 INR
EPS
-24,16 INR
Shares outstanding
15,83 მლნ.
No. of employees
319
News stories
From web sources and news partners
About Mangalam Drugs and Organics Ltd
CEO-
Employees319
Founded1972
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
492,60 მლნ.
583,76 მლნ.
672,87 მლნ.
571,19 მლნ.
Cost of goods sold
330,60 მლნ.
370,74 მლნ.
493,56 მლნ.
331,52 მლნ.
Cost of revenue
330,60 მლნ.
370,74 მლნ.
493,56 მლნ.
331,52 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,33 მლნ.
102,64 მლნ.
90,62 მლნ.
89,10 მლნ.
Operating expense
236,67 მლნ.
271,95 მლნ.
280,80 მლნ.
270,38 მლნ.
Total operating expenses
567,27 მლნ.
642,69 მლნ.
774,36 მლნ.
601,90 მლნ.
Operating income
-74,66 მლნ.
-58,93 მლნ.
-101,49 მლნ.
-30,71 მლნ.
Other non operating income
278,00 ათ.
1,11 მლნ.
-40,69 მლნ.
-
EBT including unusual items
-124,67 მლნ.
-98,35 მლნ.
-132,71 მლნ.
-67,46 მლნ.
EBT excluding unusual items
-124,67 მლნ.
-98,35 მლნ.
-133,12 მლნ.
-67,46 მლნ.
Income tax expense
-51,20 მლნ.
5,00 ათ.
1,49 მლნ.
8,93 მლნ.
Effective tax rate
41,07%
-0,01%
-1,12%
-13,23%
Other operating expenses
115,06 მლნ.
124,69 მლნ.
143,61 მლნ.
140,43 მლნ.
Net income
-73,46 მლნ.
-98,36 მლნ.
-134,20 მლნ.
-76,39 მლნ.
Net profit margin
-14,91%
-16,85%
-19,94%
-13,37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
9,06 მლნ.
-
Interest expense
-50,28 მლნ.
-40,53 მლნ.
-
-36,75 მლნ.
Net interest expenses
-50,28 მლნ.
-40,53 მლნ.
9,06 მლნ.
-36,75 მლნ.
Depreciation and amortization charges
46,29 მლნ.
44,61 მლნ.
46,58 მლნ.
40,85 მლნ.
EBITDA
-29,14 მლნ.
-25,28 მლნ.
-63,99 მლნ.
14,85 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები